IL10 and melanoma: In another murine melanoma model, selective deletion of A2A receptors in myeloid cells leads to significantly reduced IL-10 production by MDSCs, an increase in activated CD8+ T cells and NK cells, and delayed primary tumor growth and metastasis (36).